Fusi-zone cream 15 g

Tradename

Fuzi-zone

Fusi-zone

Composition

Each 100 mg of cream contains:

fusidic acid 20 mg

betamethasone valerate 1 mg

Auxiliary components:

macrogolcetostearate; cetostearyl alcohol, stearyl alcohol; chlorocresol; sodium dihydrogen phosphate dihydrate; liquid paraffin, soft white paraffin; sodium hydroxide, purified water.

Properties

Fusi-zone is a combined preparation containing corticosteroids betamethasone and fusidic acid, which has an antibacterial effect.

Betamethasone has a pharmacological effect, suppressing local immune responses, incl. vasodilation, swelling and soreness.

Fusidic acid is an antibiotic with predominant activity against gram-positive bacteria. In particular, fusidic acid is active against bact Staphylococcus aureus, Propionibacterium acnes and corynebacteria, and inhibits protein

Indications

Dermatitis, allergic eczema and toxidermia, infected with microorganisms sensitive to fusidic acid.

Method of administration and dosage:

Outwardly.

Contraindications

-increased sensitivity to drug components.

Considering the presence of GCS in the composition of the drug Fuzi-zon, the following conditions and diseases:

-rosacea;

Side effects

On the part of the skin and skin appendages: infrequently — rash, exacerbation of eczema, skin irritation, itching, burning or tingling sensation of the skin; frequency unknown skin atrophy, contact dermatitis, urticaria, erythema, dry skin.

Although these reactions were not observed in clinical studies of the drug Fuzi-zon@, external use of GCS can lead to telangiectasias and striae, especially with prolonged use.

As in the case of other corticosteroids, folliculitis (steroid acne), hypertrichosis, perioral dermatitis, depigmentation, hemorrhagic rash, rosacea, prickly heat, skin maceration and systemic effects of corticosteroids may develop.